Reuters logo
BRIEF-Neurocrine announces proposed convertible senior notes offering
April 25, 2017 / 8:21 PM / 8 months ago

BRIEF-Neurocrine announces proposed convertible senior notes offering

April 25 (Reuters) - Neurocrine Biosciences Inc-

* Neurocrine announces proposed convertible senior notes offering

* Neurocrine Biosciences announces intent to offer $450 million of convertible senior notes due 2024 in a private offering Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below